1. Home
  2. WSR vs ABUS Comparison

WSR vs ABUS Comparison

Compare WSR & ABUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WSR
  • ABUS
  • Stock Information
  • Founded
  • WSR 1998
  • ABUS 2005
  • Country
  • WSR United States
  • ABUS United States
  • Employees
  • WSR N/A
  • ABUS N/A
  • Industry
  • WSR Real Estate Investment Trusts
  • ABUS Biotechnology: Pharmaceutical Preparations
  • Sector
  • WSR Real Estate
  • ABUS Health Care
  • Exchange
  • WSR Nasdaq
  • ABUS Nasdaq
  • Market Cap
  • WSR 628.6M
  • ABUS 685.7M
  • IPO Year
  • WSR 2010
  • ABUS N/A
  • Fundamental
  • Price
  • WSR $12.51
  • ABUS $3.15
  • Analyst Decision
  • WSR Strong Buy
  • ABUS Strong Buy
  • Analyst Count
  • WSR 2
  • ABUS 4
  • Target Price
  • WSR $15.00
  • ABUS $5.50
  • AVG Volume (30 Days)
  • WSR 227.6K
  • ABUS 704.7K
  • Earning Date
  • WSR 07-30-2025
  • ABUS 07-31-2025
  • Dividend Yield
  • WSR 4.32%
  • ABUS N/A
  • EPS Growth
  • WSR 26.93
  • ABUS N/A
  • EPS
  • WSR 0.61
  • ABUS N/A
  • Revenue
  • WSR $155,128,000.00
  • ABUS $6,403,000.00
  • Revenue This Year
  • WSR $2.00
  • ABUS $3.35
  • Revenue Next Year
  • WSR $5.14
  • ABUS N/A
  • P/E Ratio
  • WSR $20.51
  • ABUS N/A
  • Revenue Growth
  • WSR 6.69
  • ABUS N/A
  • 52 Week Low
  • WSR $11.78
  • ABUS $2.71
  • 52 Week High
  • WSR $15.36
  • ABUS $4.73
  • Technical
  • Relative Strength Index (RSI)
  • WSR 52.08
  • ABUS 37.60
  • Support Level
  • WSR $12.19
  • ABUS $3.29
  • Resistance Level
  • WSR $12.65
  • ABUS $3.65
  • Average True Range (ATR)
  • WSR 0.26
  • ABUS 0.13
  • MACD
  • WSR 0.03
  • ABUS -0.03
  • Stochastic Oscillator
  • WSR 79.82
  • ABUS 14.29

About WSR Whitestone REIT

Whitestone REIT is a real estate investment trust (REIT) engaged in owning and operating commercial properties in culturally diverse markets in metropolitan areas. The company's primary business objective is to increase shareholder value by acquiring, owning, and operating Community Centered Properties. Its property portfolio includes retail and mixed-use properties located in business friendly locations in and around Austin, Chicago, Dallas-Fort Worth, Houston, Phoenix, and San Antonio. The properties are convenience-focused: merchandised with a mix of service-oriented tenants providing food (restaurants and grocers), self-care (health and fitness), services (financial and logistics), education, and entertainment to the surrounding communities.

About ABUS Arbutus Biopharma Corporation

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.

Share on Social Networks: